RRS: Cohort Study of Risk Reducing Salpingectomy
Study Details
Study Description
Brief Summary
Women undergoing surgical sterilization will be interested in risk reducing salpingectomy, and surgeons performing the procedure will be able to successfully complete the salpingectomy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Salpingectomy Participants will be offered a risk-reducing salpingectomy, and if they choose this options the surgeon will proceed with a salpingectomy. |
Procedure: Salpingectomy
|
Active Comparator: Traditional sterilization Participants will be offered a risk-reducing salpingectomy, and those that choose a traditional sterilization will be in this treatment arm. |
Procedure: Traditional sterilization
|
Outcome Measures
Primary Outcome Measures
- Percent of women accepting RRS [12 months]
Determination of patient demand/interest in pursuing RRS for sterilization during 12-month study period
Secondary Outcome Measures
- Percent of women with successful RRS completion [12 months]
Feasibility will be defined as number (%) of successful RRS completion when intended
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Women > 35 years requesting sterilization as interval procedure OR at time of cesarean delivery
-
At least one living child
-
English or Spanish speaking
-
Sterilization planned as interval (laparoscopic) procedure via Family Planning Clinic services or at time of delivery
-
Delivery by cesarean section (planned or following labor)
Exclusion Criteria:
-
Age < 30
-
Medical complications that increase risk for surgical bleeding (e.g. Idiopathic thrombocytopenic purpura (ITP); von Willebrand disease (vWD); need for prophylactic or therapeutic anticoagulation)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of North Carolina Hosptials | Chapel Hill | North Carolina | United States | 27599 |
Sponsors and Collaborators
- University of North Carolina, Chapel Hill
- Medtronic - MITG
Investigators
- Principal Investigator: Matthew L Zerden, MD, MPH, University of North Carolina, Chapel Hill
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 14-0337